These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6128757)

  • 1. Levodopa and receptor sensitivity modification in tardive dyskinesia.
    Casey DE; Gerlach J; Bjørndal N
    Psychopharmacology (Berl); 1982; 78(1):89-92. PubMed ID: 6128757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dopamine antagonists in spontaneous and tardive dyskinesia.
    Fog R
    Psychopharmacology Suppl; 1985; 2():118-21. PubMed ID: 2860655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological mechanisms underlying tardive dyskinesia.
    Gerlach J
    Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M; Friedhoff AJ; Diamond F
    Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
    [No Abstract]   [Full Text] [Related]  

  • 6. Coexistent tardive dyskinesia and parkinsonism.
    Jankovic J; Casabona J
    Clin Neuropharmacol; 1987 Dec; 10(6):511-21. PubMed ID: 2892586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tardive dyskinesia: I. Physiopathology and treatment].
    Andrade LA; Bertolucci PH; Pereira JS
    Arq Neuropsiquiatr; 1984 Dec; 42(4):362-70. PubMed ID: 6152578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.
    Miller R; Chouinard G
    Biol Psychiatry; 1993 Nov; 34(10):713-38. PubMed ID: 7904833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.
    Lieberman JA; Alvir J; Mukherjee S; Kane JM
    Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonists in clinical research for new tardive dyskinesia treatments.
    Gerlach J; Casey DE
    Mod Probl Pharmacopsychiatry; 1983; 21():97-110. PubMed ID: 6140637
    [No Abstract]   [Full Text] [Related]  

  • 13. Tardive dyskinesia.
    Gerlach J; Casey DE
    Acta Psychiatr Scand; 1988 Apr; 77(4):369-78. PubMed ID: 2898870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine antagonist and agonist treatment of tardive dyskinesia.
    Bjørndal N; Casey D; Gerlach J
    Adv Biochem Psychopharmacol; 1980; 24():541-5. PubMed ID: 6105800
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
    Glazer WM; Bowers MB; Charney DS; Heninger GR
    Biol Psychiatry; 1989 Jul; 26(3):224-33. PubMed ID: 2568132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case report.
    Gerding LB; Labbate LA
    Ann Clin Psychiatry; 1999 Jun; 11(2):87-9. PubMed ID: 10440526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable remission of tardive dyskinesia by L-dopa.
    Ludatscher JI
    J Clin Psychopharmacol; 1989 Feb; 9(1):39-41. PubMed ID: 2565346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.